ALS | Page 4 | The Neuro - McGill University

Main navigation

Improving research with more effective antibodies

Published: 15 October 2019

Scientists demonstrate flaws in protein detection tools, and outline a solution ...

Read more about Improving research with more effective antibodies

Solving an ALS mystery

12 Jun 2019

Overpowered synaptic activity may lead to motor neuron death

Read more about Solving an ALS mystery

An era of hope for ALS research

10 Jun 2019

The Neuro’s ALS clinical trials are at peak levels

Read more about An era of hope for ALS research

$4M for open science drug screening

4 Jun 2019

Funds will support development of precision therapies for ALS and Parkinson’s disease

Read more about $4M for open science drug screening

Angela Genge - NeuroXXceptional

22 Aug 2018

Neurologist Dr. Angela Genge is Director of the ALS Clinic and the Clinical Research Unit at The Neuro

Read more about Angela Genge - NeuroXXceptional

Tiny fish could be key to ALS breakthrough

7 Jun 2018

Gary Armstrong uses an aquarium in his new drug-screening program

Read more about Tiny fish could be key to ALS breakthrough

Carole Paquin – Living with ALS

7 Jun 2018

As her physical abilities diminish, Carole turns to the simpler things

Read more about Carole Paquin – Living with ALS

Pages

The Neuro logo

The Neuro (Montreal Neurological Institute-Hospital) is a bilingual academic healthcare institution. We are a McGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.